Hester Biosciences Ltd
NSE:HESTERBIO
Hester Biosciences Ltd
NSE:HESTERBIO
Price:
1 347.9
INR
-3.38%
Market Closed
Market Cap:
₹11.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
IN |
|
T
|
Thai Oil PCL
SET:TOP
|
TH |
|
Keweenaw Land Association Ltd
OTC:KEWL
|
US |
|
Mattioli Woods PLC
LSE:MTW
|
UK |
|
F
|
Fortune Ng Fung Food Hebei Co Ltd
SSE:600965
|
CN |
|
R
|
Riyal Investment and Development Company SCJSC
SAU:9584
|
SA |
|
S
|
Sociedad de infraestructuras de Mercado SA
SGO:SIMSA
|
CL |
|
Peraso Inc
NASDAQ:PRSO
|
US |
|
O
|
Opal Balance Investments Ltd
TASE:OPAL
|
IL |
Relative Value
The Relative Value of one
HESTERBIO
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 1 347.9 INR,
Hester Biosciences Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HESTERBIO Relative Value
HIDDEN
Multiples Across Competitors
HESTERBIO Competitors Multiples
Hester Biosciences Ltd Competitors
Hester Biosciences Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Hester Biosciences Ltd
NSE:HESTERBIO
|
11.5B INR | 3.6 | 28 | 17.3 | 22.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36B EUR | 10.1 | 32.6 | 35.1 | 35.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
